| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |